Warning Letter Roundup & Recap – Jan. 16, 2018
Executive Summary
Becton Dickinson received a scathing missive from US FDA that addresses quality systems, Medical Device Reporting and pre-market violations at the firm's Franklin Lakes, NJ, facility. It was the only device-related warning letter released by the agency this week.